Piramal Pharma Rights Issue 2023 vs Prerna Infrabuild Rights Issue 2023

Comparison between Piramal Pharma Rights Issue 2023 and Prerna Infrabuild Rights Issue 2023.

Rights Issue details

Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Piramal Pharma Rights Issue 2023 and Prerna Infrabuild Rights Issue 2023. Piramal Pharma Rights Issue 2023 is listed on BSE, NSE while Prerna Infrabuild Rights Issue 2023 is listed on BSE.

 Piramal Pharma LimitedPrerna Infrabuild Limited
LogoPiramal Pharma Rights Issue 2023 LogoPrerna Infrabuild Rights Issue 2023 Logo
Listing AtBSE, NSEBSE
Terms of PaymentFull Amount on ApplicationFull Amount on Application
Entitlement5 Rights Equity Share(s) for every 46 fully paid-up Equity Shares held on Record Date2 Rights Equity Share(s) for every 1 fully paid-up Equity Shares held on Record Date
Application FormApplication Form Application Form
Letter of Offer Letter of Offer Letter of Offer
RegistrarMUFG Intime India Pvt.Ltd.Bigshare Services Pvt.Ltd.
Lead ManagersICICI Securities Ltd.

Rights Issue Size and Price

The issue size of Piramal Pharma Rights Issue 2023 rights issue is ₹1,050.00 Crores, whereas Prerna Infrabuild Rights Issue 2023 rights issue size is ₹48.17 Crores.

 Piramal Pharma LimitedPrerna Infrabuild Limited
Issue Size12,96,29,630 shares2,40,85,020 shares
Issue Size (Amount)₹1,050.00 Crores₹48.17 Crores
Issue Price₹81 per share₹20 per share
Face Value₹10 per share₹10 per share

Rights Issue Timetable

Find all the important dates related to the rights issue. The record date of Piramal Pharma Rights Issue 2023 is Aug 02, 2023 while record date of Prerna Infrabuild Rights Issue 2023 is Apr 21, 2023.

 Piramal Pharma LimitedPrerna Infrabuild Limited
Record DateAug 02, 2023Apr 21, 2023
Credit of Rights Entitlements
Bid/Offer Opens OnAug 08, 2023May 02, 2023
Renunciation of Rights EntitlementsAug 10, 2023May 15, 2023
Bid/Offer Closes OnAug 17, 2023May 18, 2023
Deemed Date of AllotmentAug 23, 2023May 23, 2023
Credit DateAug 24, 2023May 25, 2023
Listing DateAug 28, 2023Apr 29, 2023

Financials details

Comparison of Piramal Pharma Rights Issue 2023 and Prerna Infrabuild Rights Issue 2023 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.

 Piramal Pharma LimitedPrerna Infrabuild Limited
Financial
Piramal Pharma Rights Issue 2023 Financial Information (Restated Consolidated)
Period Ended31 Mar 202131 Mar 202231 Mar 2023
Assets10,899.7812,797.0414,522.56
Revenue6,479.016,834.907,306.66
Profit After Tax835.03375.96-186.46
Net Worth5,076.756,069.945,968.45
Reserves and Surplus4,488.625,290.695,181.79
Total Borrowing2,910.194,023.285,504.77
Amount in ₹ Crore
Prerna Infrabuild Limited Financial Information (Restated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and SurplusTotal Borrowing
31-Mar-2040.3910.410.0132.6410.274.67
31-Mar-2139.264.60-0.1432.5010.133.25
31-Mar-2243.4223.865.8738.3716.000.85
31-Dec-2277.7213.547.0545.4223.0520.59
Amount in ₹ Crore

Compare with others

Compare: